2026-04-17T13:13:12Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1198792025-12-04T22:33:57Zcom_2072_1057col_2072_478917col_2072_478931

00925njm 22002777a 4500 dc Colom, Joan (Colom Farran) author Casas, Miquel author Pérez de los Cobos Peris, José C. author del Río, Miquel author Roncero, Carlos author Castells, Xavier author Valero, Sergi author Eiroá Orosa, Francisco José author Batlle, Francisca author Trujols i Albet, Joan author 2018-02-15T17:03:53Z 2018-02-15T17:03:53Z 2012-10 2018-02-15T17:03:53Z The aim of this study was to evaluate the feasibility of conducting double-blind controlled randomized clinical trials using twice-a-day immediate-release oral diacetylmorphine (DAM) in heroin-dependent patients, by means of measuring the capacity of oral DAM to block opiate withdrawal and clinicians' ability to distinguish it from morphine and methadone. This was a randomized, phase II, double-blind, multicenter pilot study comparing immediate-release oral DAM, slow-release oral morphine and oral methadone administered twice a day during 10 days. Forty-five heroin-dependent patients were randomly assigned to these three treatment groups in an inpatient regime. Patients were stabilized with a mean of 350 mg (SD = 193) of immediate-release oral DAM, 108 mg (SD = 46.2) of slow-release oral morphine and 40 mg (SD = 17.9) of methadone. No statistically significant differences were found between any studied medication in clinical outcome. Neither patients nor clinicians were able to identify the administered medication. This study shows the feasibility of double-blind clinical trials using b.i.d. immediate-release oral DAM allowing further phase III clinical trials in the process of introducing oral DAM as a medication for heroin-dependent patients not responding to standard maintenance treatments. Drogoaddicció Opi Desintoxicació de les drogues Drug addiction Opium Drug detoxification Feasibility of Double-Blind Clinical Trials with Oral Diacetylmorphine: A Randomized Controlled Phase II Study in an Inpatient Setting